Hudson Bay Capital Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-74,532
Closed -$171K 1011
2022
Q3
$171K Sell
74,532
-200,468
-73% -$607K ﹤0.01% 925
2022
Q2
$778K Buy
275,000
+63,500
+30% +$224K 0.01% 959
2022
Q1
$960K Buy
211,500
+96,500
+84% +$532K 0.01% 835
2021
Q4
$934K Buy
+115,000
New +$1.13M 0.01% 811
2020
Q4
Sell
-65,855
Closed -$1.22M 611
2020
Q3
$1.22M Sell
65,855
-94,145
-59% -$1.67M 0.02% 404
2020
Q2
$2.85M Sell
160,000
-25,000
-14% -$380K 0.05% 268
2020
Q1
$1.7M Buy
185,000
+55,000
+42% +$820K 0.04% 280
2019
Q4
$2.23M Sell
130,000
-40,000
-24% -$534K 0.05% 269
2019
Q3
$1.77M Buy
170,000
+85,000
+100% +$1.14M 0.05% 271
2019
Q2
$1.33M Sell
85,000
-10,000
-11% -$179K 0.03% 309
2019
Q1
$1.74M Buy
95,000
+5,000
+6% +$88.6K 0.02% 492
2018
Q4
$1.5M Buy
90,000
+52,500
+140% +$1.22M 0.02% 564
2018
Q3
$1.06M Buy
37,500
+7,500
+25% +$215K 0.01% 567
2018
Q2
$849K Buy
+30,000
New +$893K 0.01% 657
2018
Q1
Sell
-40,000
Closed -$1.17M 780
2017
Q4
$1.17M Buy
+40,000
New +$1.09M 0.03% 375
2017
Q2
Sell
-55,635
Closed -$1.33M 567
2017
Q1
$1.33M Hold
55,635
0.02% 565
2016
Q4
$943K Hold
55,635
0.02% 483
2016
Q3
$1.34M Hold
55,635
0.03% 280
2016
Q2
$1.48M Hold
55,635
0.05% 217
2016
Q1
$1.53M Sell
55,635
-7,700
-12% -$185K 0.07% 108
2015
Q4
$1.97M Sell
63,335
-94,383
-60% -$2.86M 0.11% 113
2015
Q3
$4.16M Sell
157,718
-34,295
-18% -$1.15M 0.18% 86
2015
Q2
$6.93M Buy
+192,013
New +$6.74M 0.21% 103

Other funds holding CLLS

Hudson Bay Capital Management's CLLS Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 74,532 shares — an estimated $171K sold.

Hudson Bay Capital Management first reported a position in CLLS in Q2 2015 and held it in 23 quarters. The position peaked at $6.93M in Q2 2015. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

  • Hudson Bay Capital Management reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 74,532 Cellectis shares in Q4 2022, an estimated $171K.
  • Hudson Bay Capital Management first reported a position in Cellectis in Q2 2015 and held it in 23 quarters.
  • Hudson Bay Capital Management's Cellectis position peaked at $6.93M in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.